Ligand Pharmaceuticals (LGND)

Ligand Pharmaceuticals

LGND

#4227

Rank

$2.09 B

Marketcap

🇺🇸 United States

Country

$110.72

Share price

-4.10%

Change (1 day)

96.06%

Change (1 year)

Ligand Pharmaceuticals - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year	P/B ratio	Change
2024-12-31	N/A	-100%
2023-12-31	1.78	-5.93%
2022-12-31	1.89	-39.92%
2021-12-31	3.14	39.46%
2020-12-31	2.25	-1.43%
2019-12-31	2.29	-54.48%
2018-12-31	5.02	-27.23%
2017-12-31	6.90	20.55%
2016-12-31	5.73	-26.69%
2015-12-31	7.81	-81.7%
2014-12-31	42.7	96.65%
2013-12-31	21.7	30.23%
2012-12-31	16.7	-41.6%
2011-12-31	28.5	-179.5%
2010-12-31	-35.9	-153.08%
2009-12-31	67.6	-369.41%
2008-12-31	-25.1	-260.47%
2007-12-31	15.6	-60.73%
2006-12-31	39.8	-639.8%
2005-12-31	-7.38	-34.58%
2004-12-31	-11.3	-60.61%
2003-12-31	-28.6	-652.3%
2002-12-31	5.18

P/B ratio for similar companies or competitors

Company	P/B ratio	P/B ratio differencediff.	Country
Amgen AMGN	20.1	641.26%	🇺🇸 USA
Spectrum Pharmaceuticals SPPI	7.89	191.38%	🇺🇸 USA
GlaxoSmithKline GSK	3.82	41.28%	🇬🇧 UK
Merck MRK	5.54	104.79%	🇺🇸 USA
Pfizer PFE	1.52	-43.82%	🇺🇸 USA
Eli Lilly LLY	49.8	1,739.14%	🇺🇸 USA
Bristol-Myers Squibb BMY	6.67	146.36%	🇺🇸 USA
Baxter BAX	2.12	-21.61%	🇺🇸 USA
Johnson & Johnson JNJ	5.29	95.52%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Ligand Pharmaceuticals (LGND) - P/B ratio

P/B ratio as of November 2024 : 2.71